MyAverix Finance
US · Healthcare
Acrivon Therapeutics, Inc. Common Stock (ACRV)
Biotechnology
Acrivon Therapeutics, Inc. Common Stock (ACRV) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ACRV
Acrivon Therapeutics, Inc. Common Stock (ACRV) — FAQ
What is ACRV's P/E ratio?
The price-to-earnings (P/E) ratio for Acrivon Therapeutics, Inc. Common Stock (ACRV) is 25.00 (data as of 2026-05-24).
Does Acrivon Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Acrivon Therapeutics, Inc. Common Stock (ACRV). Check the MyAverix Finance app for the latest dividend data.
What sector is Acrivon Therapeutics, Inc. Common Stock in?
Acrivon Therapeutics, Inc. Common Stock (ACRV) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ACRV listed on?
ACRV is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.